1,026 results on '"Kirchhof, Bernd"'
Search Results
2. Correction: 170 years of data-mining: history and future
3. LASER FLARE PHOTOMETRY IN PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT: An Evaluation of 2,487 Cases
4. GMS Ophthalmology Cases – An Open Access Journal
5. Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography
6. Spontaneous progression of a full-thickness macular microhole to a lamellar macular hole in spectral domain optical coherence tomography
7. 170 years of data-mining: history and future
8. Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial
9. SriniVas Sadda, Andrew Schachat, Charles Wilkinson, David Hinton, Peter Wiedemann, K. Bailey Freund, David Sarraf (eds): Ryanʼs Retina, 3 Volume Set 7th Edition, Elsevier, 2022 (eBook ISBN: 9780323722148; Hardcover ISBN: 9780323722131)
10. Initiale Diagnostik und Indikationsstellung zur Anti-Vascular-Endothelial Growth-Factor-Therapie bei Netzhauterkrankungen: Vergleich der Befundung durch Studienarzt versus Reading Center (ORCA/OCEAN-Studie)
11. The Use of Dog Guides for Orientation and Mobility by Individuals With the Argus II Retinal Prosthesis: A Case Series
12. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion
13. Preexisting epiretinal membrane is associated with pseudophakic cystoid macular edema
14. Prof. Dr. med. Dr. h.c. mult. Gerd Meyer-Schwickerath inventor of light coagulation on his 100th birthday (July 10, 2020)
15. Autologous Translocation of the Choroid and RPE in Patients with Geographic Atrophy
16. Vascular Abnormalities
17. Vitrectomy in Retinal Vascular Disease: Surgical Principles
18. Cryosurgery in Retinal Vascular Disease
19. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion
20. Ryan's Retina, 3 Volume Set 7th Edition
21. Die zweite Meinung per Telemedizin in der Augenheilkunde.
22. Reply
23. Therapeutic Approaches to Macular Oedema
24. The influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathy
25. Macular morphology in former preterm and full-term infants aged 4 to 10 years
26. Chirurgische Therapie
27. SriniVas Sadda, Andrew Schachat, Charles Wilkinson, David Hinton, Peter Wiedemann, K. Bailey Freund, David Sarraf (eds): Ryanʼs Retina, 3 Volume Set 7th Edition, Elsevier, 2022 (eBook ISBN: 9780323722148; Hardcover ISBN: 9780323722131)
28. Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study
29. Polymorphisms in Vascular Endothelial Growth Factor Receptor 2 Are Associated with Better Response Rates to Ranibizumab Treatment in Age-related Macular Degeneration
30. Special Anatomy and Pathology in Intraocular Microsurgery
31. Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial
32. Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy
33. Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration — long term results
34. Surgical Therapy
35. Long-term Stability of Vascular Endothelial Growth Factor Suppression Time Under Ranibizumab Treatment in Age-Related Macular Degeneration
36. The SECURE Study: Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration
37. Augenrat: 'Wo drückt' die Netzhaut in der Zweitmeinungssprechstunde?
38. Functional analysis and associated factors of the peripapillary retinal nerve fibre layer in former preterm and full-term infants
39. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
40. Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration
41. Vascular Endothelial Growth Factor in Patients with Exudative Age-related Macular Degeneration Treated with Ranibizumab
42. Der kranke Glaskörper: Missbildungen, Entwicklungsstörungen und Trübungen
43. Risk Alleles in CFH and ARMS2 Are Independently Associated with Systemic Complement Activation in Age-related Macular Degeneration
44. Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy Results from a Randomized Clinical Trial
45. Response to anti-VEGF therapy in patients with subretinal fluid and pigment epithelial detachment on spectral-domain optical coherence tomography
46. “Smart Resources” by Parul Ichhpujani and Sahil Thakur (2018) Springer Series: Current Practices in Ophthalmology 260 black/white illustrations, 419 illustrations in colour ISBN: 978-981-13-0139-1 Springer Singapore
47. Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration — monthly injections versus pro re nata
48. Upregulation of TGF-ß1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition
49. Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life
50. Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.